Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Progesterone receptor phosphorylation complexities in defining a functional role.

Takimoto GS, Horwitz KB.

Trends Endocrinol Metab. 1993 Jan-Feb;4(1):1-7.

PMID:
18407126
2.

Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer.

Birrell SN, Butler LM, Harris JM, Buchanan G, Tilley WD.

FASEB J. 2007 Aug;21(10):2285-93. Epub 2007 Apr 5. Review.

PMID:
17413000
5.

Evaluation of the prognostic significance of androgen receptor expression in metastatic breast cancer.

Schippinger W, Regitnig P, Dandachi N, Wernecke KD, Bauernhofer T, Samonigg H, Moinfar F.

Virchows Arch. 2006 Jul;449(1):24-30. Epub 2006 Apr 21.

PMID:
16628414
6.

MAPK signal specificity: the right place at the right time.

Murphy LO, Blenis J.

Trends Biochem Sci. 2006 May;31(5):268-75. Epub 2006 Apr 17. Review.

PMID:
16603362
7.

An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen.

Doane AS, Danso M, Lal P, Donaton M, Zhang L, Hudis C, Gerald WL.

Oncogene. 2006 Jun 29;25(28):3994-4008. Epub 2006 Feb 20.

PMID:
16491124
8.

Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation.

Burd CJ, Petre CE, Morey LM, Wang Y, Revelo MP, Haiman CA, Lu S, Fenoglio-Preiser CM, Li J, Knudsen ES, Wong J, Knudsen KE.

Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2190-5. Epub 2006 Feb 6.

9.

Estrogen receptor target gene: an evolving concept.

Carroll JS, Brown M.

Mol Endocrinol. 2006 Aug;20(8):1707-14. Epub 2006 Jan 5. Review.

PMID:
16396959
10.
11.

Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators.

Schiff R, Massarweh SA, Shou J, Bharwani L, Arpino G, Rimawi M, Osborne CK.

Cancer Chemother Pharmacol. 2005 Nov;56 Suppl 1:10-20. Review.

PMID:
16273359
12.
13.

Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1.

Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, Szary AJ, Eeckhoute J, Shao W, Hestermann EV, Geistlinger TR, Fox EA, Silver PA, Brown M.

Cell. 2005 Jul 15;122(1):33-43.

14.

Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells.

Proietti C, Salatino M, Rosemblit C, Carnevale R, Pecci A, Kornblihtt AR, Molinolo AA, Frahm I, Charreau EH, Schillaci R, Elizalde PV.

Mol Cell Biol. 2005 Jun;25(12):4826-40.

15.

Stem/progenitor cells in mouse mammary gland development and breast cancer.

Li Y, Rosen JM.

J Mammary Gland Biol Neoplasia. 2005 Jan;10(1):17-24. Review.

PMID:
15886883
16.

Progesterone receptor isoforms A and B: temporal and spatial differences in expression during murine mammary gland development.

Aupperlee MD, Smith KT, Kariagina A, Haslam SZ.

Endocrinology. 2005 Aug;146(8):3577-88. Epub 2005 May 5.

PMID:
15878961
18.

Human progesterone receptor displays cell cycle-dependent changes in transcriptional activity.

Narayanan R, Edwards DP, Weigel NL.

Mol Cell Biol. 2005 Apr;25(8):2885-98.

19.

The progesterone receptor/estradiol receptor association and the progestin-triggered S-phase entry.

Migliaccio A, Castoria G, Di Domenico M, Ballaré C, Beato M, Auricchio F.

Ernst Schering Res Found Workshop. 2005;(52):39-54. Review. No abstract available.

PMID:
15704467

Supplemental Content

Support Center